CTRI/2022/05/042891尚未招募3 期
A randomized placebo controlled trial to assess the effect of angustura vera on activity of daily living in osteoarthritis
Dr Girendra Pal Homoeopathic Hospital and Research Centre0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patient who gave consent for the study
- •2. Patient aged 35 years or more
- •3. Patient of both sex are included
- •4. Previously diagnosed cases of osteoarthritis
- •5. Patient suffering from sign and symptoms suggestive of osteoarthritis based on clinical history and examination finding
排除标准
- •1. Terminal stage of knee OA
- •2. Patient with raised levels of serum uric acid, positive rheumatoid factor,
- •c- reactive protein with clinical evidence of arthritis
- •3. Pregnant women and lactating mothers will not be included in the study
- •4. Patient below 35 years of age
- •5.Cases with severe systemic illness
- •6. Patient pursuing other treatment and not ready to leave it
研究者
相似试验
已完成
4 期
Does cholecalciferol (vitamin D3) improve patient-level outcomes for people with chronic kidney disease on dialysis25-Hydroxyvitamin D insufficiency and deficiencychronic kidney disease stage 5D (dialysis)Renal and Urogenital - Kidney diseaseMetabolic and Endocrine - Other metabolic disordersMusculoskeletal - Other muscular and skeletal disordersACTRN12611000199910Westmead Hospital, Sydney West Area Health Service62
进行中（未招募）
1 期
Melatonin treatment for sleep disturbance in eye disorders: Sandman Trialcircadian sleep-wake disturbances associated with ocular disease.MedDRA version: 21.1 Level: PT Classification code 10009191 Term: Circadian rhythm sleep disorder System Organ Class: 10029205 - Nervous system disordersEUCTR2017-002189-39-GBniversity of Oxford80
尚未招募
3 期
A study to assess the role of indicated Homoeopathic medicines for management of pain in the cases of Calcaneal SpurCTRI/2024/04/065561Dr M P K Homoeopathic Medical College Hospital And Research Centre
进行中（未招募）
不适用
Safety and efficacy of tocilizumab in combination with placebo compared with tocilizumab in combination with methotrexate, with possible addition of other disease-modifying antirheumatic drugs (DMARDs), in patients with moderate to severe active rheumatoid arthritis who are not responding adequately to their current therapy with methotrexateRheumatoid ArthritisEUCTR2008-001847-20-LVF Hoffmann-La Roche Ltd.470
进行中（未招募）
不适用
Safety and efficacy of tocilizumab in combination with placebo compared with tocilizumab in combination with methotrexate, with possible addition of other disease-modifying antirheumatic drugs (DMARDs), in patients with moderate to severe active rheumatoid arthritis who are not responding adequately to their current therapy with methotrexateMedDRA version: 14.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid ArthritisEUCTR2008-001847-20-SEF Hoffmann-La Roche Ltd.470